Form 4 Tracker
TABUTEAU HERRIOT

Director, Chief Executive Officer, 10% Owner · 6 filings · Latest: Aug 5, 2026

Axsome Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AXSM
Herriot Tabuteau—Dec 2, 2025
Proposed Sale
$142.0949,252$7.0M—
AXSM
Herriot Tabuteau—Nov 5, 2025
Proposed Sale
$135.6921,775$3.0M—
AXSM
Herriot Tabuteau—Nov 4, 2025
Proposed Sale
$134.9350,459$6.8M—
AXSM
Herriot Tabuteau—Nov 3, 2025
Proposed Sale
$135.7591,705$12.4M—
AXSM
Herriot Tabuteau—Oct 8, 2025
Proposed Sale
$118.7112,774$1.5M—
AXSM
Herriot Tabuteau—Oct 7, 2025
Proposed Sale
$118.6413,390$1.6M—
AXSM
Herriot Tabuteau—Oct 6, 2025
Proposed Sale
$119.9419,220$2.3M—
AXSM
Herriot Tabuteau—Sep 16, 2025
Proposed Sale
$114.1019,719$2.2M—
AXSM
Herriot Tabuteau—Sep 15, 2025
Proposed Sale
$116.7815,254$1.8M—
AXSM
Herriot Tabuteau—Sep 12, 2025
Proposed Sale
$118.4227,907$3.3M—

← Previous

Page 2 of 2